[Dongxing Securities] the first medical research KuaiBao: steady performance, actively expand a variety of business models
[Tianxiang Investment] the first medicine: the performance maintains steady growth
[Tianxiang Investment] first Pharmaceutical (600833): net profit belonging to the parent company decreased by 0.23% compared with the same period last year.
No Data